Breast cancer

publication date: Oct 31, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
A number of drugs have been identified which have the potential to reduce the risk of breast cancer. A large meta-analysis published in 2009 identified tamoxifen, raloxifene and tibolone as potential agents (Ann Int Med 2009;151:703). The included studies were highly heterogenous in terms of risk stratification, patient age, etc.


Sorry this page is a subscription service. To find out more about subscribing, please click here.

If you are already a user, please login.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.


The online handbook is a subscription service. To find out more about subscribing, please click here.